Top Markets
#1 Trillions Trillions +5,128.37%
#2 DeFiChain DeFiChain +1,700.88%
#3 Bedrock Bedrock +163.86%
#4 Siren Siren +91.29%
#5 KONET KONET +60.65%
#6 inSure DeFi inSure DeFi +59.52%
#7 Banana For Scale Banana For Scale +44.28%
#8 Aria.AI Aria.AI +38.69%
#9 Syndicate Syndicate +37.36%
#10 Janction Janction +32.88%
Coin of the day
Trillions Trillions
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Ovoca Bio plc Ovoca Bio plc

Ovoca Bio plc

OVB
Kedudukan dalam Saham #99999
Ovoca Bio plc, a clinical-stage biopharmaceutical company, engages in the... Ovoca Bio plc, a clinical-stage biopharmaceutical company, engages in the development and commercialization of novel product candidates for the treatment of female sexual dysfunctions. It is developing BP-101, a medicinal treatment for premenopausal women with hypoactive sexual desire disorder, which is in phase II clinical study in Australia and New Zealand, and in phase III clinical trials in Russia. It also engages in mineral exploration, as well as provides support services. The company was formerly known as Ovoca Gold plc and changed its name to Ovoca Bio plc in July 2018. Ovoca Bio plc was incorporated in 1985 and is based in Dublin, Ireland.
Harga Saham
$0.09933121
Modal Pasaran
$29.15K
Perubahan (1 hari)
0.57%
Perubahan (1 tahun)
449.49%
Negara
IE
Perdagangan Ovoca Bio plc (OVB)

Kategori

Healthcare
Nisbah P/B bagi Ovoca Bio plc (OVB)
Nisbah P/B pada March 2026 TTM: 0.32
Menurut laporan kewangan dan harga saham terkini Ovoca Bio plc, nisbah P/B semasa (TTM) ialah 0.32. Pada akhir 2022, nisbah P/B syarikat ialah 0.64.
Sejarah nisbah P/B untuk Ovoca Bio plc dari 2001 hingga 2026
Nisbah P/B pada akhir setiap tahun
Tahun Nisbah P/B Ubah
2026 (TTM) 0.32 5.10%
2023 0.30 -53.15%
2022 0.64 -29.64%
2021 0.91 118.10%
2020 0.42 -3.84%
2019 0.43 -6.34%
2018 0.46 53.47%
2017 0.30 -32.59%
2016 0.45 47.37%
2015 0.30 -7.99%
2014 0.33 9.22%
2013 0.30 -0.88%
2012 0.31 -37.76%
2011 0.49 -30.05%
2010 0.70 56.65%
2009 0.45 86.66%
2008 0.24 -82.53%
2007 1.37 8.35%
2006 1.27 -10.71%
2005 1.42 46.67%
2004 0.97 -4.43%
2003 1.01 -25.12%
2002 1.35 -22.97%
2001 1.76 0.00%
Nisbah P/B untuk syarikat atau pesaing yang serupa
Syarikat Nisbah P/B Perbezaan Nisbah P/B Negara
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
 5.6573 1,694.26%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3842 1,924.80%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
 2.4551 678.66%
US
UCB SA UCB SA
UCB SA
UCB.BR
 4.364 1,284.08%
BE
Argenx SE Argenx SE
Argenx SE
ARGX.US
 5.9034 1,772.31%
NL